Politics & Government

Sen. Blumenthal Submits Bill Limiting Antipsychotics Use in Nursing Homes

Another group of advocates for the elderly also is seeking a 50 percent reduction on the use of the drugs in Connecticut nursing homes.

 

State and federal officials are pushing to limit nursing homes in Connecticut from using antipsychotic drugs, which some say the facilities use too often to calm or quiet patients with dementia.

Democrat Richard Blumenthal, Connecticut’s junior senator, announced Tuesday that he has submitted legislation to limit the use of so-called “off-label” anti-psychotic medications in nursing homes, according to a report by ctmirror.org. Blumenthal said such those drugs are frequently used by nursing home staff as a form of “chemical restraint” for more difficult to manage patients, many of whom suffer from dementia.

Find out what's happening in Southburywith free, real-time updates from Patch.

"It is a form of elder abuse,” Blumenthal said in announcing the legislation. “It's chemical restraint -- no less pernicious and insidious than physical restraint of patients -- and it should be stopped."

At the same time, groups advocating for the elderly in Connecticut announced that they would seek to limit the use of antipsychotics in nursing homes by 50 percent.

Find out what's happening in Southburywith free, real-time updates from Patch.

Connecticut nursing homes use off-label antipsychotic drugs 24 percent to 65 percent of the time, while the national average is 23.9 percent, Nancy B. Shaffer, state ombudsman for Connecticut’s office of long-term care, told ctmirror.org.

In other legislative news, Blumenthal recently offered his support for a bill that would regulate "misleading" colleges and punish unsatisfactory schools.


Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.

We’ve removed the ability to reply as we work to make improvements. Learn more here